Ocular Therapeutix
OCUL
#3706
Rank
โ‚ฌ2.94 B
Marketcap
13,84ย โ‚ฌ
Share price
28.06%
Change (1 day)
56.37%
Change (1 year)

Revenue for Ocular Therapeutix (OCUL)

Revenue in 2025 (TTM): โ‚ฌ50.11 Million

According to Ocular Therapeutix's latest financial reports the company's current revenue (TTM ) is โ‚ฌ47.91 Million. In 2024 the company made a revenue of โ‚ฌ61.23 Million an increase over the revenue in the year 2023 that were of โ‚ฌ52.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ocular Therapeutix from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ50.11 M-18.16%
2024 โ‚ฌ61.23 M15.83%
2023 โ‚ฌ52.86 M10.13%
2022 โ‚ฌ48 M24.92%
2021 โ‚ฌ38.42 M171.6%
2020 โ‚ฌ14.14 M274.97%
2019 โ‚ฌ3.77 M116.92%
2018 โ‚ฌ1.73 M8.54%
2017 โ‚ฌ1.6 M-10.66%
2016 โ‚ฌ1.79 M12.09%
2015 โ‚ฌ1.6 M152.14%
2014 โ‚ฌ0.63 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Intersect ENT
XENT
โ‚ฌ91.69 M 91.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
โ‚ฌ69.5 M 45.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚ฌ1.14 B 2,280.38%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
โ‚ฌ0.10 B 116.56%๐Ÿ‡บ๐Ÿ‡ธ USA